-
公开(公告)号:US20220143195A1
公开(公告)日:2022-05-12
申请号:US17430721
申请日:2020-02-04
Applicant: NURIX THERAPEUTICS, INC.
Inventor: Diasuke KATO , Zef KNOST , Jeffrey MIHALIC , Daniel W. ROBBINS , Arthur T. SANDS
Abstract: The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.